|Systematic (IUPAC) name|
|Oral, eye drops|
|Molecular mass||260.309 g/mol|
|(what is this?)|
Suprofen was originally used as tablet, but oral uses have been discontinued due to renal effects. It was subsequently used exclusively as a topical ophthalmic solution, typically to prevent miosis during and after ophthalmic surgery. This application has been discontinued as well, at least in the US.
- Janssen, Paul A.; Van Daele, Georges H. P.; Boey, Jozef M. "Antiphlogistic aroyl-substituted phenylacetic acid derivatives" (1974) DE 2353357
- Nies A S (1988). "Renal effects of nonsteroidal anti-inflammatory drugs". Agents and actions 24: 95–106. doi:10.1007/978-3-0348-9160-8_9. PMID 3142236.
- Guidance for FDA Staff and Industry Compliance Policy Guides Manual, Sec. 460.200
- Drugs.com: suprofen ophthalmic
|This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.|